Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography

Journal of the Chinese Medical Association

Volumn 71, Issue 12, 2008, Pages 605-609

  Chan, Hoi Hung ^a,b,c   Lai, Kwok Hung ^a,b   Lin, Chiun Ku ^a,b   Tsai, Wei Lun ^a   Lo, Gin Ho ^a,b   Hsu, Ping I ^a,b   Wei, Min Ching ^a   Wang, E Ming ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

ERCP; Pancreatitis; Somatostatin

Indexed keywords

SOMATOSTATIN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BILIARY TRACT DISEASE; BILIARY TRACT DRAINAGE; CHOLANGITIS; CLINICAL TRIAL; COMMON BILE DUCT STONE; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; HUMAN; HYPERAMYLASEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; PANCREAS DUCT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 59149105331     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70002-4     Document Type: Article

References (23)

1. Adamek HE, Albert J, Weitz M, Breer H, Schilling D, Riemann JF. A prospective evaluation of magnetic resonance cholangiopancreatography in patients with suspected bile duct obstruction. Gut 1998;43:680-3.
2. Lomanto D, Pavone P, Laghi A, Panebianco V, Mazzocchi P, Fiocca F, Lezoche E, et al. Magnetic resonance cholangiopancreatography in the diagnosis of biliopancreatic diseases. Am J Surg 1997;174:33-8.
3. Bibao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography: a study of 10000 cases. Gastroenterology 1976;70:314-20.
4. Stanten R, Frey CF. Pancreatitis after endoscopic retrograde cholangiopancreatography: an underreported disease whose severity is often unappreciated. Arch Surg 1990;125:1032-5.
5. Rolny P, Anderberg B, Ihse I, Lindstrom E, Olaison G, Arvill A. Pancreatitis after sphincter of Oddi manometry. Gut 1990; 31:821-4.
6. Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999;31:125-30.
7. Male R, Lehman G, Sherman S. Severe and fatal complications from diagnostic and therapeutic ERCPs. Gastrointest Endosc 1994;40:A29.
8. Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999;49: 593-8.
9. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis N, Papadimitriou N, Mathouet N, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002;55:470-5.
10. Budzynska A, Marek T, Nowak A, Kaczor K, Nowakowska-Dulawa E. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33:766-72.
11. Prat F, Amaris J, Ducot B, Bocquentin M, Fritsch J, Choury AD, Pelletier G, et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002;56:202-8.
12. Deviere J, Le Moine O, van Laethem JL, Eisendrath P, Ghilain A, Severs N, Cohard M. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
13. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Francesco VD. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996;335:919-23.
14. Zheng M, Chen Y, Yang X, Li J, Zhang Y, Zeng Q. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2007;7:6.
15. Bordas JM, Toledo-Pimentel V, Liach J, Elena M, Mondelo F, Gines A, Teres J. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc 1998;47:230-4.
16. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
17. Baxter JN, Jenkins SA, Day DW, Shields R. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg 1985;72:382-5.
18. Ahrendt SA, McGuire GE, Lillemoe KD, Trias M, Kaloo A, Pitt HA. Somatostatin inhibits sphincter of Oddi motility. Gastroenterology 1990;98:242A.
19. Lai KH, Lo GH, Cheng JS, Fu MT, Wang EM, Chan HH, Wang YY, et al. Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis. Gut 2001;49: 843-6.
20. Testoni PA, Caporuscio S, Bagnolo F, Lella F. Twenty-four hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy. Endoscopy 1999;31:131-6.
21. Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis, after ERCP: an updated meta-analysis. Gastrointest Endosc 2007;65: 624-32.
22. Rudin D, Kiss A, Wetz RV, Sottile VM. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol 2007;22: 977-83.
23. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.